Homeopathics Buyers Can't Change Trial Terms, Boiron Says
Homeopathic remedy maker Boiron Inc. urged a California federal judge Tuesday to reject a bid by a class of consumers to redefine the terms of their upcoming, two-phase false labeling trial,...To view the full article, register now.
Already a subscriber? Click here to view full article